Table 5.
Results of the left ventricular hypertrophy * multivariable logistic regression analysis in the study population.
Variable | Model 3 | Model 4 | ||||||
---|---|---|---|---|---|---|---|---|
OR Unstandardized | 95% C.I. | OR Standardized ** | p | OR Unstandardized | 95% C.I. | OR Standardized ** | p | |
BPs, mmHg | 1.012 | 0.997–1.027 | 1.242 | 0.120 | - | - | - | - |
BPd, mmHg | 1.010 | 0.983–1.038 | 1.112 | 0.461 | - | - | - | - |
HR, bpm | 0.988 | 0.964–1.012 | 0.871 | 0.316 | 0.984 | 0.960–1.010 | 0.840 | 0.224 |
LVEF BP, % | 1.001 | 0.955–1.050 | 1.008 | 0.956 | 1.011 | 0.961–1.063 | 1.063 | 0.675 |
LAVI, ml/m2 | 1.047 | 1.011–1.084 | 1.381 | 0.009 | 1.048 | 1.010–1.088 | 1.389 | 0.014 |
P wave time, ms | 1.027 | 1.001–1.055 | 1.341 | 0.042 | 1.022 | 0.995–1.050 | 1.261 | 0.118 |
QRS time, ms | 1.048 | 1.014–1.084 | 1.553 | 0.006 | 1.046 | 1.010–1.082 | 1.517 | 0.012 |
Sokolow–Lyon index, mm | 1.027 | 0.988–1.068 | 1.211 | 0.176 | 1.034 | 0.992–1.077 | 1.264 | 0.112 |
Cornell index, mm | 1.082 | 1.029–1.137 | 1.525 | 0.002 | 1.071 | 1.017–1.128 | 1.443 | 0.010 |
Lewis index, mm | 1.053 | 1.017–1.090 | 1.540 | 0.004 | 1.053 | 1.016–1.091 | 1.539 | 0.005 |
NT-proBNP, pg/mL | 1.002 | 1.000–1.005 | 1.537 | 0.058 | 1.002 | 1.000–1.004 | 1.468 | 0.077 |
hs-TnT, pg/mL | 1.078 | 1.014–1.147 | 1.453 | 0.016 | 1.081 | 1.012–1.156 | 1.472 | 0.021 |
Fasting glucose, mg/dL | 1.011 | 1.000–1.023 | 1.224 | 0.056 | 1.011 | 0.997–1.025 | 1.218 | 0.132 |
120 min glucose, mg/dL | 1.007 | 1.000–1.014 | 1.300 | 0.063 | 1.008 | 1.000–1.015 | 1.344 | 0.046 |
Fasting insulin, µUL/mL | 1.011 | 0.975–1.048 | 1.079 | 0.555 | 1.019 | 0.981–1.060 | 1.145 | 0.329 |
120 Insulin, µUL/mL | 1.002 | 0.999–1.006 | 1.154 | 0.231 | 1.003 | 0.999–1.008 | 1.236 | 0.103 |
HbA1c, % | 1.961 | 1.299–2.961 | 1.460 | 0.001 | 2.127 | 1.212–3.731 | 1.528 | 0.009 |
HOMA -IR | 1.045 | 0.936–1.167 | 1.100 | 0.434 | 1.063 | 0.942–1.199 | 1.142 | 0.322 |
hsCRP, mg/L | 1.029 | 0.975–1.085 | 1.106 | 0.296 | 1.028 | 0.975–1.084 | 1.103 | 0.306 |
WHR | 3.194 | 0.074–137.489 | 1.118 | 0.545 | 2.485 | 0.048–127.726 | 1.092 | 0.651 |
% fat | 21.797 | 0.052–9204.292 | 1.261 | 0.318 | 16.272 | 0.031–8603.827 | 1.234 | 0.383 |
Total fat mass, kg | 1.050 | 1.011–1.090 | 1.558 | 0.011 | 1.046 | 1.006–1.088 | 1.510 | 0.024 |
Total lean mass, kg | 1.076 | 1.025–1.130 | 2.184 | 0.003 | 1.071 | 1.019–1.125 | 2.067 | 0.007 |
Android fat mass, kg | 1.390 | 1.058–1.826 | 1.491 | 0.018 | 1.380 | 1.027–1.853 | 1.478 | 0.032 |
Gynoid fat mass, kg | 1.406 | 1.104–1.793 | 1.609 | 0.006 | 1.384 | 1.082–1.771 | 1.573 | 0.010 |
Legs fat mass, kg | 1.147 | 1.018–1.293 | 1.462 | 0.025 | 1.143 | 1.012–1.292 | 1.450 | 0.032 |
Visceral mass, kg | 1.608 | 1.124–2.300 | 1.567 | 0.009 | 1.581 | 1.064–2.347 | 1.542 | 0.023 |
A/G fat mass ratio, % | 1.013 | 0.997–1.030 | 1.350 | 0.112 | 1.013 | 0.995–1.031 | 1.340 | 0.151 |
G/T fat mass ratio, % | 0.978 | 0.844–1.133 | 0.941 | 0.765 | 1.001 | 0.857–1.171 | 1.004 | 0.985 |
A/T fat mass ratio, % | 1.232 | 1.028–1.476 | 1.572 | 0.024 | 1.246 | 1.026–1.512 | 1.610 | 0.026 |
Legs/T fat mass ratio, % | 0.959 | 0.907–1.014 | 0.746 | 0.137 | 0.964 | 0.909–1.023 | 0.776 | 0.226 |
Risk SCORE, % | 0.988 | 0.909–1.075 | 0.999 | 0.788 | 0.969 | 0.883–1.063 | 0.998 | 0.504 |
BPs: systolic blood pressure; BPd: diastolic blood pressure; mmHg: millimeters of mercury; HR: heart rate; bpm: beats per minute; LVEF BP: left ventricular ejection fraction biplane Simpson’s method; LAVI: left atrial volume index; NT-proBNP: N-terminal pro-brain natriuretic peptide; hs-TnT: high-sensitivity troponin T; HbA1c: hemoglobin A1c; HOMA-IR: homeostasis model assessment of insulin resistance; CRP: C-reactive protein; WHR: waist-hip ratio; A: android; G: gynoid, T: total; SCORE: Systematic Coronary Risk Estimation; GFR: glomerular filtration rate Cockcroft-Gault Equation; Model 3: adjusted for age, sex, GFR; Model 4: model 3 + additional adjustment for: history of hypertension, diabetes, atrial fibrillation, myocardial infarction, coronary heart disease, heart failure, peripheral artery disease, stroke and BP ≥ 140 and/or ≥ 90 mmHg. * The left ventricular mass (LVM) index was calculated by the formula LVM/BSA, and the LVH was defined as LVMI ≥ 115 g/m2 for men and ≥ 95 g/m2 for women. ** Standardized for independent variables.